Basit öğe kaydını göster

dc.contributor.authorKurtuncu, Murat
dc.contributor.authorTuncer, Asli
dc.contributor.authorUygunoglu, Ugur
dc.contributor.authorCaliskan, Zeynep
dc.contributor.authorKokenli Paksoy, Aysenur
dc.contributor.authorEfendi, Husnu
dc.contributor.authorSiva, Aksel
dc.date.accessioned2020-06-21T12:19:33Z
dc.date.available2020-06-21T12:19:33Z
dc.date.issued2019
dc.identifier.issn1300-0667
dc.identifier.issn1309-4866
dc.identifier.urihttps://doi.org/10.5152/npa.2017.19387
dc.identifier.urihttps://hdl.handle.net/20.500.12712/10425
dc.descriptionWOS: 000510207600008en_US
dc.descriptionPubMed: 31903035en_US
dc.description.abstractIntroduction: The management of multiple sclerosis (MS) has become more complicated after the introduction of new diagnostic and treatment options. Despite the abundance of guidelines, the experience of physicians still plays a major role in the management of patients. This study aimed to define differences in behavior patterns between general neurologists (GNs) and MS specialists (MSSs). Methods: We conducted a survey of 36 questions to 318 neurologists, including 33 MSSs. The survey covered topics including laboratory investigations, pregnancy, and treatment. Results: Our study found many differences between GNs and MSSs in terms of management, the most important being treatment initiation and switching. GNs had a tendency to initiate treatment later than MSSs however, they tended to switch treatment faster. Our study also showed that GNs ordered magnetic resonance imaging (MRI) more frequently than MSSs, even if patients were clinically stable. Moreover, although GNs more frequently relied on MRI, they did not consider brain atrophy as an important measure in the follow-up of their patients. Furthermore, GNs considered replacement therapy less often than MSSs, even in patients with vitamin D deficiency. Discussion: Our study revealed important discrepancies between the management patterns of GNs and MSSs in MS patients. These findings suggest the need for a national education program for GNs on MSSs.en_US
dc.description.sponsorshipNovartis, TurkeyNovartisen_US
dc.description.sponsorshipThis study was sponsored by Novartis, Turkey.en_US
dc.language.isoengen_US
dc.publisherAvesen_US
dc.relation.isversionof10.5152/npa.2017.19387en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMultiple sclerosisen_US
dc.subjectgeneral neurologistsen_US
dc.subjectmultiple sclerosis specialistsen_US
dc.subjectmanagement differencesen_US
dc.titleDifferences Between General Neurologists and Multiple Sclerosis Specialists in the Management of Multiple Sclerosis Patients: A National Surveyen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume56en_US
dc.identifier.issue4en_US
dc.identifier.startpage269en_US
dc.identifier.endpage272en_US
dc.relation.journalNoropsikiyatri Arsivi-Archives of Neuropsychiatryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster